|MDACC Study No:||2010-0907 (clinicaltrials.gov NCT No: NCT01400503)|
|Title:||An Open-label, Multicenter Study to Evaluate the Safety of Long-term Treatment with Siltuximab in Subjects with Multicentric Castleman’s Disease|
|Principal Investigator:||Luis E. Fayad|
|Treatment Agent:||CNTO 328|
|Study Description:||The goal of this clinical research study is to learn more about the long term |
safety of siltuximab in patients with multicentric Castleman's disease.
Researchers also want to learn if siltuximab can help to control multicentric